Cover Page
Cover Page - shares | 3 Months Ended | |
Mar. 31, 2020 | Apr. 29, 2020 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity File Number | 001-31950 | |
Entity Registrant Name | MONEYGRAM INTERNATIONAL, INC. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 16-1690064 | |
Entity Address, Address Line One | 2828 N. Harwood St., 15th Floor | |
Entity Address, City or Town | Dallas | |
Entity Address, State or Province | TX | |
Entity Address, Postal Zip Code | 75201 | |
City Area Code | 214 | |
Local Phone Number | 999-7552 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Title of 12(b) Security | Common stock, $0.01 par value | |
Trading Symbol | MGI | |
Security Exchange Name | NASDAQ | |
Entity Common Stock, Shares Outstanding | 63,438,859 | |
Amendment Flag | false | |
Document Period End Date | Mar. 31, 2020 | |
Document Fiscal Year Focus | 2020 | |
Document Fiscal Period Focus | Q1 | |
Entity Central Index Key | 0001273931 | |
Current Fiscal Year End Date | --12-31 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
ASSETS | ||
Cash and cash equivalents | $ 131 | $ 146.8 |
Settlement assets | 2,944.5 | 3,237 |
Property and equipment, net | 169.6 | 176.1 |
Goodwill | 442.2 | 442.2 |
Other assets | 208.4 | 182.9 |
Total assets | 3,895.7 | 4,185 |
LIABILITIES | ||
Payment service obligations | 2,944.5 | 3,237 |
Debt, net | 877.5 | 850.3 |
Pension and other postretirement benefits | 76.8 | 77.5 |
Accounts payable and other liabilities | 264.6 | 260.6 |
Total liabilities | 4,163.4 | 4,425.4 |
COMMITMENTS AND CONTINGENCIES (NOTE 12) | ||
STOCKHOLDERS’ DEFICIT | ||
Participating convertible preferred stock - series D, $0.01 par value, 200,000 shares authorized, 71,282 issued at March 31, 2020 and December 31, 2019 | 183.9 | 183.9 |
Common stock, $0.01 par value, 162,500,000 shares authorized, 65,061,090 shares issued at March 31, 2020 and December 31, 2019 | 0.7 | 0.7 |
Additional paid-in capital | 1,118.8 | 1,116.9 |
Treasury Stock, Value | 12.3 | 18.3 |
Retained loss | (1,488.5) | (1,460.1) |
Accumulated other comprehensive loss | (70.3) | (63.5) |
Total stockholders’ deficit | (267.7) | (240.4) |
Total liabilities and stockholders’ deficit | $ 3,895.7 | $ 4,185 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Mar. 31, 2020 | Dec. 31, 2019 |
Common stock, par value (usd per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (shares) | 162,500,000 | 162,500,000 |
Common Stock, Shares, Issued | 64,434,490 | 65,061,090 |
Treasury stock (shares) | 2,384,065 | 2,329,906 |
D Stock | ||
Participating convertible preferred stock, par value (usd per share) | $ 0.01 | $ 0.01 |
Participating convertible preferred stock, shares authorized (shares) | 200,000 | 200,000 |
Participating convertible preferred stock, shares issued (shares) | 71,282 | 71,282 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
REVENUE | ||
Fee and other revenue | $ 280.8 | $ 301 |
Investment revenue | 10.1 | 14.4 |
Total revenue | 290.9 | 315.4 |
EXPENSES | ||
Fee and other commissions expense | 143.2 | 149.6 |
Investment commissions expense | 3 | 6.3 |
Direct transaction expense | 8.2 | 5 |
Total commissions and direct transaction expenses | 154.4 | 160.9 |
Compensation and benefits | 53.4 | 59.4 |
Transaction and operations support | 38 | 52.1 |
Occupancy, equipment and supplies | 14.9 | 15.4 |
Total operating expenses | 277.8 | 306.8 |
OPERATING INCOME | 13.1 | 8.6 |
Other expenses | ||
Interest expense | 23.8 | 13.9 |
Other non-operating expense | 1.1 | 1.6 |
Total other expenses | 24.9 | 15.5 |
Loss before income taxes | (11.8) | (6.9) |
Income tax expense | 9.7 | 6.6 |
NET LOSS | $ (21.5) | $ (13.5) |
LOSS PER COMMON SHARE | ||
Basic (usd per share) | $ (0.28) | $ (0.21) |
Weighted-average outstanding common shares and equivalents used in computing loss per share | ||
Basic and diluted weighted-average outstanding common shares and equivalents used in computing loss per share | 77.4 | 64.8 |
Diluted | 76.4 | 64.5 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Comprehensive (Loss) Income - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Statement of Comprehensive Income [Abstract] | ||
NET LOSS | $ (21.5) | $ (13.5) |
OTHER COMPREHENSIVE LOSS | ||
Net change in unrealized holding gains on available-for-sale securities arising during the period | 0 | 0.2 |
Net change in pension liability due to amortization of prior service credit and net actuarial loss, net of tax benefit of $0.1 for the three months ended March 31, 2020 and 2019 | 0.4 | 0.8 |
Unrealized non-U.S. dollar translation adjustments, net of tax benefit of $0.0 for the three months ended March 31, 2020 and 2019 | (7.2) | (3.1) |
Other comprehensive loss | (6.8) | (2.1) |
COMPREHENSIVE LOSS | $ (28.3) | $ (15.6) |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Comprehensive (Loss) Income (Parenthetical) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Statement of Comprehensive Income [Abstract] | ||
Net change in pension liability, tax | $ 0 | $ 0.2 |
Tax benefit, net | 0 | 0 |
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Plan Amendments, Tax Effect | 0 | 0 |
Unrealized foreign currency translation gains (losses), tax | $ 0 | $ 0 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Cash Flows - USD ($) | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Interest Paid, Excluding Capitalized Interest, Operating Activities | $ 17,600,000 | $ 12,800,000 |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net loss | (21,500,000) | (13,500,000) |
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] | ||
Depreciation and amortization | 17,100,000 | 19,000,000 |
Signing bonus amortization | 12,500,000 | 11,700,000 |
Amortization of debt discount and debt issuance costs | 2,900,000 | 700,000 |
Non-cash compensation and pension expense | 3,100,000 | 4,100,000 |
Signing bonus payments | (25,000,000) | (10,100,000) |
Change in other assets | (21,200,000) | (4,000,000) |
Change in accounts payable and other liabilities | 5,700,000 | (12,000,000) |
Other non-cash items, net | 0 | 4,400,000 |
Net cash (used in) provided by operating activities | (26,400,000) | 300,000 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Purchases of property and equipment | (10,100,000) | (12,700,000) |
Net cash used in investing activities | (10,100,000) | (12,700,000) |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Principal payments on debt | (1,600,000) | (2,500,000) |
Payments to tax authorities for stock-based compensation | (700,000) | (700,000) |
Net cash provided by (used in) financing activities | 20,700,000 | (3,200,000) |
NET CHANGE IN CASH AND CASH EQUIVALENTS | (15,800,000) | (15,600,000) |
CASH AND CASH EQUIVALENTS—Beginning of period | 146,800,000 | 145,500,000 |
CASH AND CASH EQUIVALENTS—End of period | 131,000,000 | 129,900,000 |
Proceeds from (Repayments of) Lines of Credit | $ (23,000,000) | $ 0 |
Consdensed Consolidated Stateme
Consdensed Consolidated Statements of Stockholders' Deficit - USD ($) $ in Millions | Total | Cumulative effect of adoption of ASU 2018-02 | Preferred Stock | Common Stock | Additional Paid-In Capital | Retained Loss | Retained LossCumulative effect of adoption of ASU 2018-02 | Accumulated Other Comprehensive Loss | Accumulated Other Comprehensive LossCumulative effect of adoption of ASU 2018-02 | Treasury Stock |
Beginning Balance at Dec. 31, 2018 | $ (268.8) | $ 0 | $ 183.9 | $ 0.6 | $ 1,046.8 | $ (1,403.6) | $ 15.1 | $ (67.5) | $ (15.1) | $ (29) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Net (loss) income | (13.5) | (13.5) | ||||||||
Stock-based compensation activity | 2.1 | 2.6 | (9.5) | 9 | ||||||
Other comprehensive loss | (2.1) | (2.1) | ||||||||
Ending Balance at Mar. 31, 2019 | (282.3) | 183.9 | 0.6 | 1,049.4 | (1,411.5) | (84.7) | (20) | |||
Beginning Balance at Dec. 31, 2019 | (240.4) | 183.9 | 0.7 | 1,116.9 | (1,460.1) | (63.5) | (18.3) | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Net (loss) income | (21.5) | (21.5) | ||||||||
Stock-based compensation activity | 1 | 1.9 | (6.9) | 6 | ||||||
Other comprehensive loss | (6.8) | (6.8) | ||||||||
Ending Balance at Mar. 31, 2020 | $ (267.7) | $ 183.9 | $ 0.7 | $ 1,118.8 | $ (1,488.5) | $ (70.3) | $ (12.3) |
Description of the Business and
Description of the Business and Basis of Presentation | 3 Months Ended |
Mar. 31, 2020 | |
Description of the Business and Basis of Presentation [Abstract] | |
Description of the Business and Basis of Presentation | Description of the Business and Basis of Presentation References to “MoneyGram,” the “Company,” “we,” “us” and “our” are to MoneyGram International, Inc. and its subsidiaries. Nature of Operations — MoneyGram offers products and services under its two reporting segments: Global Funds Transfer and Financial Paper Products. The Global Funds Transfer segment provides global money transfer services and bill payment services to consumers through two primary distribution channels: walk-in and digital. Through our walk-in channel, we offer services through third-party agents, including retail chains, independent retailers, post offices and other financial institutions. Additionally, we have limited Company-operated retail locations. We offer solutions such as moneygram.com, mobile solutions, fintech and digital partners, wallets and account deposit services as part of our digital channel. The Financial Paper Products segment provides official check outsourcing services and money orders through financial institutions and agent locations. Basis of Presentation — The accompanying unaudited condensed consolidated financial statements of MoneyGram are prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. The Condensed Consolidated Balance Sheets are unclassified due to the timing uncertainty surrounding the payment of settlement obligations. Impact of Novel Coronavirus (“COVID-19” ) On Our Financial Statements — The global spread and unprecedented impact of COVID-19 is complex and rapidly-evolving. In March 2020, the World Health Organization declared COVID-19 a global pandemic and recommended extensive containment and mitigation measures worldwide. The outbreak has reached all of the regions in which we do business, and governmental authorities around the world have implemented numerous measures attempting to contain and mitigate the effects of the virus, including travel bans and restrictions, border closings, quarantines, shelter-in-place orders, shutdowns, limitations or closures of non-essential businesses, school closures and social distancing requirements. The global spread of COVID-19 and actions taken in response to the virus have negatively affected our workforce, agents, customers, financial markets, employment rates, consumer spending and credit markets, caused significant economic and business disruption, volatility and financial uncertainty, and led to a significant economic downturn. We have assessed various accounting estimates and other matters, including those that require consideration of forecasted financial information, in context of the unknown future impacts of COVID-19 using information that is reasonably available to us at this time. The accounting estimates and other matters we assessed included, but were not limited to, our goodwill and other long-lived assets, allowance for credit losses, pension and other postretirement benefits and valuation allowances for tax assets. Based on our current assessment of these estimates, the Company recorded an increase in its deferred tax asset valuation allowance of $10.6 million, of which $10.1 million related to balances which existed at the beginning of the year. See Note 11 — Income Taxes for more information. There was no other material impact to our condensed consolidated financial statements as of and for the quarter ended March 31, 2020, based on the Company's assessment of its estimates. As additional information becomes available to us, our future assessment of these estimates, including our expectations at the time regarding the duration, scope and severity of the pandemic, as well as other factors, could materially and adversely impact our consolidated financial statements in future reporting periods. Use of Estimates — The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates and assumptions are based on historical experience, future expectations and other factors and assumptions the Company believes to be reasonable under the circumstances. These estimates and assumptions are reviewed on an ongoing basis and are revised when necessary. Changes in estimates are recorded in the period of change. Actual amounts may differ from these estimates. Recent Accounting Pronouncements and Related Developmen ts — In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . The new credit impairment standard changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, entities will be required to use a new forward-looking expected loss model that generally will result in the earlier recognition of allowances for credit losses. For available-for-sale debt securities with unrealized losses, entities will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. To further assist with adoption and implementation of ASU 2016-13, the FASB issued the following ASUs: • ASU 2018-19 (Issued November 2018) — Codification Improvements to Topic 326, Financial Instruments - Credit Losses • ASU 2019-04 (Issued April 2019) — Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments • ASU 2019-05 (Issued May 2019) — Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief • ASU 2019-10 (Issued November 2019) — Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates • ASU 2019-11 (Issued November 2019) — Codification Improvements to Topic 326, Financial Instruments - Credit Losses • ASU 2020-02 (Issued February 2020) — Financial Instruments - Credit Losses (Topic 326) and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842) (SEC Update) • ASU 2020-03 (Issued March 2020) — Codification Improvements to Financial Instruments ASU 2019-10 changed the effective date of ASU 2016-13 for public business entities that meet the definition of a Securities and Exchange Commission ("SEC") filer but that are eligible to be a smaller reporting company to fiscal years beginning after December 15, 2022. MoneyGram is a smaller reporting company and, as such, will adopt the amendments in these standards in 2023. We are still evaluating these ASUs, but we do not believe the adoption will have a material impact on our consolidated financial statements. In August 2018, the FASB issued ASU 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefits Plans. The amendments in this standard require that entities now disclose the weighted-average interest credit ratings for cash balance plans and other plans with promised interest credit ratings and an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period, as well as clarify and remove certain other disclosures. This standard is effective for fiscal years ending after December 15, 2020, and, as such, its disclosure requirements will be reflected in the 2020 Annual Report on Form 10-K. This standard does not impact our consolidated financial statements. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting . The amendments in this ASU provide, if certain criteria are met, optional expedients and exceptions for applying the GAAP requirements for contract modifications, hedging relationships and sales or transfers of debt securities, that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform through December 31, 2022. The adoption of this ASU is optional and the election can be made anytime during the effective period. The amendments in this ASU are effective as of March 12, 2020 through December 31, 2022. MoneyGram is currently evaluating the impact of this standard and has not yet determined whether we will elect the optional expedients. The Company has determined that there have been no other recently adopted or issued accounting standards that had, or will have, a material impact on its condensed consolidated financial statements. |
Restructuring and Reorganizatio
Restructuring and Reorganization Costs | 3 Months Ended |
Mar. 31, 2020 | |
Restructuring and Reorganization Costs [Abstract] | |
Restructuring and Reorganization Costs | Reorganization Costs In the fourth quarter of 2019, the Company committed to an operational plan to reduce overall operating expenses, including the elimination of approximately 120 positions ac ross the Company (the “2019 Organizational Realignment”). The workforce reduction was designed to streamline operations and structure the Company in a way that will be more agile and aligned around our plan to execute market-specific strategies tailored to different segments. The workforce reduction was substantially completed in the first quarter of 2020 with $7.5 million of costs incurred consisting primarily of one-time termination benefits for employee severance and related costs, which are recorded in “Compensation and benefits” on the Condensed Consolidated Statements of Operations in the Global Funds Transfer reporting segment. The following table is a roll-forward of the reorganization costs accrual as of March 31, 2020: (Amounts in millions) 2019 Organizational Realignment Balance, December 31, 2019 $ 4.6 Expenses 0.7 Cash payments (4.6) Balance, March 31, 2020 $ 0.7 The following table is a summary of the cumulative reorganization costs incurred to date in operating expenses as of March 31, 2020: (Amounts in millions) 2019 Organizational Realignment Balance, December 31, 2019 $ 6.8 First quarter 2020 0.7 Total cumulative reorganization costs incurred to date $ 7.5 |
Settlement Assets and Payment S
Settlement Assets and Payment Service Obligations | 3 Months Ended |
Mar. 31, 2020 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Settlement Assets and Payment Service Obligations | Settlement Assets and Payment Service Obligations The Company records payment service obligations relating to amounts payable under money transfers, money orders and consumer payment service arrangements. These obligations are recognized by the Company at the time the underlying transaction occurs. The Company records corresponding settlement assets, which represent funds received or to be received for unsettled money transfers, money orders and consumer payments. The following table summarizes the amount of settlement assets and payment service obligations: (Amounts in millions) March 31, 2020 December 31, 2019 Settlement assets: Settlement cash and cash equivalents $ 1,371.6 $ 1,531.1 Receivables, net 579.5 715.5 Interest-bearing investments 989.1 985.9 Available-for-sale investments 4.3 4.5 $ 2,944.5 $ 3,237.0 Payment service obligations $ (2,944.5) $ (3,237.0) |
Fair Value Measurement
Fair Value Measurement | 3 Months Ended |
Mar. 31, 2020 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring | Fair Value Measurement Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, or the exit price, in an orderly transaction between market participants on the measurement date. The following table summarizes the Company’s financial assets and liabilities measured at fair value by hierarchy level on a recurring basis: (Amounts in millions) Level 2 Level 3 Total March 31, 2020 Financial assets: Available-for-sale investments: Residential mortgage-backed securities $ 3.5 $ — $ 3.5 Asset-backed and other securities — 0.8 0.8 Forward contracts 4.3 — 4.3 Total financial assets $ 7.8 $ 0.8 $ 8.6 Financial liabilities: Forward contracts $ — $ — $ — December 31, 2019 Financial assets: Available-for-sale investments: Residential mortgage-backed securities $ 3.6 $ — $ 3.6 Asset-backed and other securities — 0.9 0.9 Forward contracts — — — Total financial assets $ 3.6 $ 0.9 $ 4.5 Financial liabilities: Forward contracts $ 0.8 $ — $ 0.8 Assets and liabilities that are disclosed at fair value — Debt and interest-bearing investments are carried at amortized cost; however, the Company estimates the fair value of debt for disclosure purposes. The fair value of the first lien credit facility is estimated using an observable market quotation (Level 2). As of March 31, 2020 and December 31, 2019, the fair value of the first lien credit facility w as $460.9 million and $577.6 million, respectively, with carrying value of $640.2 million and $641.8 million, respectively. The fair value of the second lien credit facility is estimated using unobservable market inputs (Level 3), including broker quotes for comparable traded securities and yield curves. As of March 31, 2020 and December 31, 2019, the fair value of the second lien credit facility was $185.7 million and $236.7 million, respectively, with carrying value of $254.6 million and $251.4 million, respectively. The carrying amounts for the Company's cash and cash equivalents, settlement cash and cash equivalents, receivables, interest-bearing investments and payment service obligations approximate fair value as of March 31, 2020 and December 31, 2019. |
Investment Portfolio
Investment Portfolio | 3 Months Ended |
Mar. 31, 2020 | |
Investments [Abstract] | |
Investment Portfolio | Investment Portfolio The following table shows the components of the investment portfolio: (Amounts in millions) March 31, 2020 December 31, 2019 Cash $ 1,500.1 $ 1,675.4 Money market securities 2.5 2.5 Cash and cash equivalents (1) 1,502.6 1,677.9 Interest-bearing investments 989.1 985.9 Available-for-sale investments 4.3 4.5 Total investment portfolio $ 2,496.0 $ 2,668.3 (1) For purposes of the disclosure of the investment portfolio as a whole, the cash and cash equivalents balance includes settlement cash and cash equivalents. The following table is a summary of the amortized cost and fair value of available-for-sale investments: (Amounts in millions) Amortized Gross Fair March 31, 2020 Residential mortgage-backed securities $ 3.1 $ 0.4 $ 3.5 Asset-backed and other securities 0.2 0.6 0.8 Total $ 3.3 $ 1.0 $ 4.3 December 31, 2019 Residential mortgage-backed securities $ 3.3 $ 0.3 $ 3.6 Asset-backed and other securities 0.2 0.7 0.9 Total $ 3.5 $ 1.0 $ 4.5 As of March 31, 2020 and December 31, 2019, 81% and 80%, respectively, of the fair value of the available-for-sale portfolio were invested in residential mortgage-backed securities issued by U.S. government agencies. These securities have the implicit backing of the U.S. government and the Company expects to receive full par value upon maturity or pay-down, as well as all interest payments. Contractual Maturities — Actual maturities may differ from contractual maturities as borrowers may have the right to call or prepay obligations, sometimes without call or prepayment penalties. Maturities of residential mortgage-backed and asset-backed and other securities depend on the repayment characteristics and experience of the underlying obligations. |
Derivative Financial Instrument
Derivative Financial Instruments | 3 Months Ended |
Mar. 31, 2020 | |
Derivative Instrument Detail [Abstract] | |
Derivative Financial Instruments | Derivative Financial Instruments The Company uses forward contracts to manage its non-U.S. dollar needs and non-U.S. dollar exchange risk arising from its assets and liabilities denominated in non-U.S. dollars. While these contracts may mitigate certain non-U.S. dollar risk, they are not designated as hedges for accounting purposes and will result in gains and losses. The Company also reports gains and losses from the spread differential between the rate set for its transactions and the actual cost of currency at the time the Company buys or sells in the open market. The following net (losses) gains related to assets and liabilities denominated in non-U.S. dollar are included in “Transaction and operations support” in the Condensed Consolidated Statements of Operations and in the "Net cash provided by operating activities" line in the Condensed Consolidated Statements of Cash Flows: Three Months Ended March 31, (Amounts in millions) 2020 2019 Net realized non-U.S. dollar loss $ (3.8) $ (3.5) Net gain from the related forward contracts 6.3 5.1 Net gain from non-U.S. dollar transactions and related forward contracts $ 2.5 $ 1.6 As of March 31, 2020 and December 31, 2019, the Company had $389.4 million an d $349.1 million, respectively, of outstanding notional amounts relating to its non-U.S. dollar forward contracts. As of March 31, 2020 and December 31, 2019, the Company reflects the following fair values of derivative forward contract instruments in its Condensed Consolidated Balance Sheets: Gross Amount of Recognized Assets Gross Amount of Offset Net Amount of Assets Presented in the Consolidated Balance Sheets (Amounts in millions) Balance Sheet Location March 31, 2020 December 31, 2019 March 31, 2020 December 31, 2019 March 31, 2020 December 31, 2019 Forward contracts Other assets $ 4.8 $ 0.2 $ (0.5) $ (0.2) $ 4.3 $ — Gross Amount of Recognized Liabilities Gross Amount of Offset Net Amount of Liabilities Presented in the Consolidated Balance Sheets (Amounts in millions) Balance Sheet Location March 31, 2020 December 31, 2019 March 31, 2020 December 31, 2019 March 31, 2020 December 31, 2019 Forward contracts Accounts payable and other liabilities $ 0.5 $ 1.0 $ (0.5) $ (0.2) $ — $ 0.8 The Company’s forward contracts are primarily executed with counterparties governed by International Swaps and Derivatives Association agreements that generally include standard netting arrangements. Asset and liability positions from forward contracts and all other non-U.S. dollar exchange transactions with the same counterparty are net settled upon maturity. The Company is exposed to credit loss in the event of non-performance by counterparties to its derivative contracts. The Company actively monitors its exposure to credit risk through the use of credit approvals and credit limits and by selecting major international banks and financial institutions as counterparties. Collateral generally is not required of the counterparties or of the Company. In the unlikely event the counterparty fails to meet the contractual terms of the derivative contract, the Company’s risk is limited to the fair value of the instrument. The Company has not had any historical instances of non-performance by any counterparties, nor does it anticipate any future instances of non-performance. |
Debt
Debt | 3 Months Ended |
Mar. 31, 2020 | |
Debt Disclosure [Abstract] | |
Debt | Debt The following is a summary of the Company's outstanding debt: (Amounts in millions, except percentages) March 31, 2020 December 31, 2019 6.95% first lien revolving credit facility due 2022 $ 23.0 $ — 7.00% first lien credit facility due 2023 640.2 641.8 13.00% second lien credit facility due 2024 254.6 251.4 Senior secured credit facilities 917.8 893.2 Unamortized debt issuance costs and debt discounts (40.3) (42.9) Total debt, net $ 877.5 $ 850.3 First Lien Credit Agreement and Revolving Credit Facility — The First Lien Credit Agreement provides for (i) a senior secured three-year revolving credit facility that may be used for revolving credit loans, swingline loans and letters of credit up to an aggregate principal amount of $35.0 million, which matures September 30, 2022 (the “First Lien Revolving Credit Facility”) and (ii) a senior secured four-year term loan facility in an aggregate principal amount of $645.0 million (the “First Lien Term Credit Facility” and together with the First Lien Revolving Credit Facility, the “First Lien Credit Facility”). As of March 31, 2020, the Company had $23.0 million borrowings und er the First Lien Revolving Credit Facility, which are used for general corporate purposes. The First Lien Credit Agreement also provides that in the event the Company’s cash balance exceeds $130.0 million at the end of any month, the Company would be required to use such excess cash to pay any outstanding obligations to the revolving lenders under our First Lien Revolving Credit Facility, and that the Company may not draw on the First Lien Revolving Credit Facility to the extent that the Company would have a cash balance in excess of $130.0 million after giving effect to such borrowing. Second Lien Credit Agreement — The Second Lien Credit Agreement provides for a second lien secured five-year term loan facility in an aggregate principal amount of $245.0 million (the “Second Lien Term Credit Facility” and together with the First Lien Credit Facility, the “Credit Facilities”). Subject to certain conditions and limitations, the Company may elect to pay interest under the Second Lien Term Credit Facility partially in cash and partially in kind. The outstanding principal balance for the Second Lien Credit Agreement is due on the maturity date. The Credit Facilities are secured by substantially all of the Company’s assets and its material domestic subsidiaries that guarantee the payment and performance of the Company’s obligations under the Credit Facilities. Debt Covenants and Other Restrictions — The Credit Facilities contain various limitations that restrict the Company’s ability to: incur additional indebtedness; create or incur additional liens; effect mergers and consolidations; make certain acquisitions or investments; sell assets or subsidiary stock; pay dividends and make other restricted payments; and effect loans, advances and certain other transactions with affiliates. In addition, the First Lien Revolving Credit Facility requires the Company and its consolidated subsidiaries (w) to maintain a minimum interest coverage ratio, (x) to maintain a minimum asset coverage ratio, (y) to not exceed a maximum first lien leverage ratio, and (z) to not exceed a total leverage ratio. The Second Lien Credit Facility requires the Company to not exceed a maximum secured leverage ratio of 5.50:1.00 commencing September 30, 2019. The asset coverage covenant contained in the First Lien Credit Agreement requires the aggregate amount of the Company’s cash and cash equivalents and other settlement assets exceed its aggregate payment service obligations. The Company's assets in excess of payment service obligations used for the asset coverage calculation were $131.0 million and $146.8 million as of March 31, 2020 and December 31, 2019, respectively. The table below summarizes the interest coverage, first lien and total leverage ratio covenants, which are calculated based on the four-fiscal quarter period ending on each quarter end beginning September 30, 2019 through the maturity of the First Lien Credit Facility: Interest Coverage Minimum Ratio First Lien Leverage Ratio Not to Exceed Total Leverage Ratio Not to Exceed July 1, 2019 through June 30, 2020 2.50:1 3.750:1 5.125:1 July 1, 2020 through December 31, 2020 2.50:1 3.500:1 5.000:1 January 1, 2021 through maturity 2.50:1 3.000:1 4.500:1 As of March 31, 2020, the Company was in compliance with its financial covenants: our interest coverage ratio was 3.374 to 1.00, our first lien leverage ratio was 2.900 to 1.00 and our total leverage ratio was 4.013 to 1.00. We continuously monitor our compliance with our debt covenants. |
Pension and Other Benefits
Pension and Other Benefits | 3 Months Ended |
Mar. 31, 2020 | |
Retirement Benefits [Abstract] | |
Pension and Other Benefits | Pension and Other Benefits The following table is a summary of net periodic benefit expense for the Company's defined benefit pension plan and supplemental executive retirement plans, collectively referred to as "Pension": Three Months Ended March 31, (Amounts in millions) 2020 2019 Interest cost $ 0.8 $ 1.7 Expected return on plan assets (0.2) (1.1) Amortization of net actuarial loss 0.5 0.9 Net periodic benefit expense $ 1.1 $ 1.5 The Company had nominal net |
Stockholders' Deficit
Stockholders' Deficit | 3 Months Ended |
Mar. 31, 2020 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Deficit | Stockholders' Deficit Common Stock — No dividends were paid during the three months ended March 31, 2020. Accumulated Other Comprehensive Loss — The following table is a summary of the significant amounts reclassified out of each component of "Accumulated other comprehensive loss": Three Months Ended (Amounts in millions) 2020 2019 Statement of Operations Location Pension and Postretirement Benefits adjustments: Amortization of net actuarial loss $ 0.5 $ 0.9 "Other non-operating expense" Total before tax 0.5 0.9 Tax benefit, net (0.1) (0.1) Total reclassified for the period, net of tax $ 0.4 $ 0.8 The following table is a summary of the changes to Accumulated other comprehensive loss by component: (Amounts in millions) Net Unrealized Gains on Securities Classified as Available-for-sale, Net of Tax Cumulative non-U.S. dollar Translation Adjustments, Net of Tax Pension and Postretirement Benefits Adjustment, Net of Tax Total January 1, 2020 $ 1.6 $ (28.1) $ (37.0) $ (63.5) Other comprehensive loss before reclassification — (7.2) — (7.2) Amounts reclassified from accumulated other comprehensive loss — — 0.4 0.4 Net current period other comprehensive (loss) income — (7.2) 0.4 (6.8) March 31, 2020 $ 1.6 $ (35.3) $ (36.6) $ (70.3) (Amounts in millions) Net Unrealized Gains on Securities Classified as Available-for-sale, Net of Tax Cumulative non-U.S. dollar Translation Adjustments, Net of Tax Pension and Postretirement Benefits Adjustment, Net of Tax Total January 1, 2019 $ 1.9 $ (24.2) $ (45.2) $ (67.5) Adoption of 2018-02 ASU — (3.7) (11.4) (15.1) Other comprehensive income (loss) before reclassification 0.2 (3.1) — (2.9) Amounts reclassified from accumulated other comprehensive loss — — 0.8 0.8 Net current period other comprehensive income (loss) 0.2 (3.1) 0.8 (2.1) March 31, 2019 $ 2.1 $ (31.0) $ (55.8) $ (84.7) |
Stock-Based Compensation
Stock-Based Compensation | 3 Months Ended |
Mar. 31, 2020 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Stock-Based Compensation | Stock-Based Compensation The following table is a summary of the Company's stock-based compensation expense: Three Months Ended March 31, (Amounts in millions) 2020 2019 Stock-based compensation expense $ 2.0 $ 2.6 Stock Options — The following table is a summary of the Company’s stock option activity: Shares Weighted- Weighted- Aggregate Options outstanding at December 31, 2019 409,296 $ 19.34 2.4 years $ — Forfeited/Expired (22,081) 20.65 Options outstanding, vested or expected to vest, and exercisable at March 31, 2020 387,215 $ 19.27 2.1 years $ — As of March 31, 2020, the Company had no unrecognized stock option expense related to outstanding options. Restricted Stock Units — In March 2020, the Company granted time-based restricted stock units, which vest in three equal installments on each anniversary of the grant date. As of March 4, 2020, the grant date, the Company had remaining authorization to issue grants of up to 1,919,406 shares under its 2005 Omnibus Incentive Plan (“2005 Plan”). If the March 2020 grants were to be fully settled in stock, an additional 1,279,888 shares of Company common stock would be needed under the 2005 Plan to be able to settle those awards. At the 2020 Annual Meeting of Stockholders, the stockholders will be asked to approve the amendment and restatement of the 2005 Plan, which includes among other items, approval for increasing the number of shares that may be issued under the plan by 8,900,000 shares. If the amendment and restatement is approved at the 2020 Annual Meeting of Stockholders, it will become effective as of May 6, 2020. The following table is a summary of the Company’s restricted stock unit activity: Total Weighted-Average Grant-Date Fair Value Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value ($000,000) Restricted stock units outstanding at December 31, 2019 2,731,758 $ 5.02 0.9 years $ 5.7 Granted 3,199,294 2.12 Vested and converted to shares (997,868) 6.90 Forfeited (99,042) 3.73 Restricted stock units outstanding at March 31, 2020 4,834,142 $ 2.74 1.6 years $ 6.3 Restricted stock units vested and deferred at March 31, 2020 54,472 $ 8.26 $ 0.1 The following table is a summary of the Company's restricted stock unit compensation information: Three Months Ended March 31, (Amounts in millions) 2020 2019 Weighted-average grant-date fair value of restricted stock units vested during the period $ 6.9 $ 8.9 Total intrinsic value of vested and converted shares $ 2.5 $ 2.5 |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2020 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes For the three months ended March 31, 2020, the Company recognized an income tax expense of $9.7 million on a pre-tax loss of $11.8 million primarily due to an increase in valuation allowance, U.S. taxation of foreign earnings, non-deductible expenses, foreign taxes net of federal income tax benefits and the reversal of tax benefits on share-based compensation, all of which were partially offset by U.S. tax credits. The change in valuation allowance was triggered by a three-year cumulative pre-tax loss position inclusive of 2020 forecasted earnings. While the Company has a long history of profitable operations prior to recent declines, the expected cumulative loss position is significant negative evidence in assessing the recoverability of our deferred tax assets. Therefore, we recorded an additional valuation allowance of $10.6 million, of which $10.1 million related to balances which existed at the beginning of the year, against our deferred tax assets for which ultimate realization is dependent upon the generation of future taxable income during the periods in which they become deductible. The valuation allowance does not, however, impact our cash position, our liquidity, or our tax returns. For the three months ended March 31, 2019, the Company recognized an income tax expense of $6.6 million on a pre-tax loss of $6.9 million primarily due to non-deductible expenses, U.S. taxation of foreign earnings, the reversal of tax benefits on share-based compensation, partially offset by U.S. tax credits net of valuation allowance. Additionally, as a result of the issuance of the final Section 965 regulations by the U.S. Treasury Department and the Internal Revenue Service (the "IRS") on January 15, 2019, the Company recorded a discrete tax expense of $0.7 million for an in crease in its one-time transition tax. Unrecognized tax benefits are recorded in “Accounts payable and other liabilities” in the Condensed Consolidated Balance Sheets. As of March 31, 2020 and December 31, 2019, the liability for unrecognized tax benefits was $18.2 million for both periods, exclusive of interest and penalties. For the three months ended March 31, 2020 and 2019 , the net amount of unrecognized tax benefits that if recognized could impact the effective tax rate was $18.2 million in both years. The Company accrues interest and penalties for unrecognized tax benefits through “Income tax (benefit) expense” in the Condensed Consolidated Statements of Operations. For the three months ended March 31, 2020 and 2019, the Company's accrual for interest and penalties increased by $0.3 million in each period. As of March 31, 2020 and December 31, 2019, the Company had a liability o f $8.6 million and $8.3 million, respectively, accrued for interest and penalties within "Accounts payable and other liabilities." As a result of the Company's litigation related to its securities losses discussed in more detail in Note 12 — Commitments and Contingencies |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Letters of Credit — At March 31, 2020, the Compan y had nominal outstanding letters of credit and $23.0 million borrowings und er the First Lien Revolving Credit Facility. Legal Proceedings — The matters set forth below are subject to uncertainties and outcomes that are not predictable. The Company accrues for these matters as any resulting losses become probable and can be reasonably estimated. Further, the Company maintains insurance coverage for many claims and litigation matters. In relation to various legal matters, including those described below, the Compan y had $57.5 million of liability recorded in “Accounts payable and other liabilities” in the Condensed Consolidated Balance Sheets as of March 31, 2020 and December 31, 2019. For the three months ended March 31, 2020 and 2019, a nominal charge was recorded for legal proceedings in “Transaction and operations support” in the Condensed Consolidated Statements of Operations. Litigation Commenced Against the Company: Class Action Securities Litigation — On November 14, 2018, a putative securities class action lawsuit was filed in the United States District Court for the Northern District of Illinois against MoneyGram and certain of its executive officers. The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and alleges that MoneyGram made material misrepresentations regarding its compliance with the stipulated order for permanent injunction and final judgment that MoneyGram entered into with the Federal Trade Commission (“FTC”) in October 2009 and with the deferred prosecution agreement (the "DPA") that MoneyGram entered into with the U.S. Attorney’s Office for the Middle District of Pennsylvania and the U.S. Department of Justice in November 2012. The lawsuit seeks unspecified damages, equitable relief, interest, and costs and attorneys’ fees. The Company believes the case is without merit and is vigorously defending this matter. We are unable to predict the outcome, or the possible loss or range of loss, if any, related to this matter. Shareholder Derivative Litigation — On February 19 and 20, 2019, two virtually identical shareholder derivative lawsuits were filed in the United States District Court for the Northern District of Texas. The suits, which have since been consolidated, purport to assert claims derivatively on behalf of MoneyGram against MoneyGram’s directors and certain of its executive officers for violations of Sections 10(b), 14(a) and 20(a) of the Securities Exchange Act of 1934 and for common-law breach of fiduciary duty and unjust enrichment. The complaints assert that the individual defendants caused MoneyGram to make material misstatements regarding MoneyGram’s compliance with the stipulated order and DPA described in the preceding paragraph and breached their fiduciary duties in connection with MoneyGram’s compliance programs. The lawsuit seeks unspecified damages, equitable relief, interest, and costs and attorneys’ fees. On December 28, 2019, another MoneyGram shareholder filed a putative derivative action suit in the Court of Chancery of the State of Delaware, New Castle County, against certain of MoneyGram’s officers and directors. The suit asserts claims for breach of fiduciary duty and other common law theories and seeks unspecified damages on behalf of MoneyGram based on allegations that the individual defendants failed to take appropriate actions to prevent or remedy noncompliance with the stipulated order and DPA described above. The Company believes the derivative cases are without merit and is vigorously defending these matters. We are unable to predict the outcome, or the possible loss or range of loss, if any, related to these matters. Books and Records Requests — The Company has received multiple requests from various putative shareholders for inspection of books and records pursuant to Section 220 of the Delaware General Corporation Law relating to the subject matter of the putative class and derivative lawsuits described in the preceding paragraphs. On February 26, 2019, two of these shareholders filed a petition in the Delaware Court of Chancery to compel MoneyGram to produce books and records in accordance with their request but have since dismissed their action. We are unable to predict the outcome, or the possible loss or range of loss, if any, related to these matters. It is possible that additional shareholder lawsuits could be filed relating to the subject matter of the class action, derivative actions and Section 220 requests. Other Matters — The Company is involved in various other claims and litigation that arise from time to time in the ordinary course of the Company’s business. Management does not believe that after final disposition any of these matters is likely to have a material adverse impact on the Company’s financial condition, results of operations or cash flows. Government Investigations: OFAC — In 2015, we initiated an internal investigation to identify any payments processed by the Company that were violations of the U.S. Department of the Treasury’s Office of Foreign Assets Control (“OFAC”) sanctions regulations. We notified OFAC of the internal investigation, which was conducted in conjunction with the Company’s outside counsel. On March 28, 2017, we filed a Voluntary Self-Disclosure with OFAC regarding the findings of our internal investigation. OFAC is currently reviewing the results of the Company’s investigation. At this time, it is not possible to determine the outcome of this matter, or the significance, if any, to our business, financial condition or operations, and we cannot predict when OFAC will conclude its review of our Voluntary Self-Disclosure. Deferred Prosecution Agreement — In November 2012, we announced that a settlement was reached with the U.S. Attorney’s Office for the Middle District of Pennsylvania (the “MDPA”) and the U.S. Department of Justice, Criminal Division, Money Laundering and Asset Recovery Section (the “U.S. DOJ”) relating to the previously disclosed investigation of transactions involving certain of our U.S. and Canadian agents, as well as fraud complaint data and the consumer anti-fraud program, during the period from 2003 to early 2009. In connection with this settlement, we entered into the DPA with the MDPA and U.S. DOJ (collectively, the “Government”) dated November 9, 2012. On November 1, 2017, the Company agreed to a stipulation with the Government that the five-year term of the Company’s DPA be extended for 90 days to February 6, 2018. Between January 31, 2018 and September 14, 2018, the Company agreed to enter into various extensions of the DPA with the Government, with the last extension ending on November 6, 2018. Each extension of the DPA extended all terms of the DPA, including the term of the monitorship for an equivalent period. The purpose of the extensions was to provide the Company and the Government additional time to discuss whether the Company was in compliance with the DPA. On November 8, 2018, the Company announced that it entered into (1) an Amendment to and Extension of Deferred Prosecution Agreement (the “Amended DPA”) with the Government and (2) a Stipulated Order for Compensatory Relief and Modified Order for Permanent Injunction (the “Consent Order”) with the FTC. The motions underlying the Amended DPA and Consent Order focus primarily on the Company’s anti-fraud and anti-money laundering programs, including whether the Company had adequate controls to prevent third parties from using its systems to commit fraud. The Amended DPA amended and extended the original DPA entered into on November 9, 2012 by and between the Company and the Government. The DPA, Amended DPA and Consent Order are collectively referred to herein as the “Agreements.” On February 25, 2020, the Company entered into an Amendment to Amendment to and Extension of DPA Agreement which extended the due date to November 8, 2020 for the final $55.0 million payment due to the Government pursuant to the Amended DPA. The Company continues to engage in discussions with the Government regarding a potential further extension of the deadline to make the final $55.0 million payment and a reduction of such payment. The Company intends to fulfil its obligation regarding the final payment and the other terms of the Amended DPA. Under the Agreements, as amended, the Company will, among other things, (1) pay an aggregate amount of $125.0 million to the Government, of which $70.0 million was paid in November 2018 and the remaining $55.0 million must be paid by November 8, 2020, and is to be made available by the Government to reimburse consumers who were the victims of third-party fraud conducted through the Company’s money transfer services, and (2) continue to retain an independent compliance monitor until May 10, 2021 to review and assess actions taken by the Company under the Agreements to further enhance its compliance program. No separate payment to the FTC is required under the Agreements. If the Company fails to comply with the Agreements, it could face criminal prosecution, civil litigation, significant fines, damage awards or regulatory consequences which could have a material adverse effect on the Company’s business, financial condition, results of operations and cash flows. NYDFS — On June 22, 2018, the Company received a request for production of documents from the New York Department of Financial Services (the “NYDFS”) related to the subject of the DPA and FTC matters described above. This request followed previous inquiries by the NYDFS regarding certain of our New York based agents. Following the June 22, 2018 request for production, the Company received and responded to several inquiries from the NYDFS related to this matter and has met with the NYDFS to discuss the matter. The NYDFS did not indicate what, if any, action it intended to take in connection with this matter, although it is possible that it could seek additional information, initiate civil litigation and/or seek to impose fines, damages or other regulatory consequences, any or all of which could have an adverse effect on the Company’s business, financial condition, results of operations and cash flows. The Company is unable to predict the outcome, or the possible loss or range of loss, if any, that could be associated with this matter. Other Matters — The Company is involved in various other government inquiries and other matters that arise from time to time. Management does not believe that after final disposition any of these other matters is likely to have a material adverse impact on the Company’s financial condition, results of operations or cash flows. Actions Commenced by the Company: Tax Litigation — The IRS completed its examination of the Company’s consolidated income tax returns through 2013 and issued Notices of Deficiency for 2005-2007 and 2009, and an Examination Report for 2008. The Notices of Deficiency and Examination Report disallow, among other items, approximately $900.0 million of ordinary deductions on securities losses in the 2007, 2008 and 2009 tax returns. In May 2012 and December 2012, the Company filed petitions in the U.S. Tax Court (“Tax Court”) challenging the 2005-2007 and 2009 Notices of Deficiency, respectively. In 2013, the Company reached a partial settlement with the IRS allowing ordinary loss treatment on $186.9 million of deductions in dispute. In January 2015, the Tax Court granted the IRS’s motion for summary judgment upholding the remaining adjustments in the Notices of Deficiency. The Company filed a notice of appeal with the Tax Court on July 27, 2015 for an appeal to the U.S. Court of Appeals for the Fifth Circuit (“Fifth Circuit”). Oral arguments were held before the Fifth Circuit on June 7, 2016, and on November 15, 2016, the Fifth Circuit vacated the Tax Court’s decision and remanded the case to the Tax Court for further proceedings. The Company filed a motion for summary judgment in the Tax Court on May 31, 2017. On August 23, 2017, the IRS filed a motion for summary judgment and its response to the Company’s motion for summary judgment. The Tax Court directed the parties to agree to a joint stipulation of facts, which the parties have filed with the court. Each party has since filed updated memorandums in support of its motions for summary judgment in the Tax Court. The Tax Court held oral arguments on this matter on September 9, 2019 and the Tax Court issued an opinion on December 3, 2019 denying the Company’s motion for summary judgment. MoneyGram disagrees with many of the U.S. Tax Court’s findings and filed a Notice of Appeal to the Fifth Circuit Court of Appeals on February 21, 2020. The January 2015 Tax Court decision was a change in facts which warranted reassessment of the Company's uncertain tax position. Although the Company believes that it has substantive tax law arguments in favor of its position and has appealed the ruling, the reassessment resulted in the Company determining that it is no longer more likely than not that its existing position will be sustained. Accordingly, the Company re-characterized certain deductions relating to securities losses to be capital in nature, rather than ordinary. The Company recorded a full valuation allowance against these losses in the quarter ended March 31, 2015. This change increased "Income tax expense" in the Consolidated Statements of Operations in the quarter ended March 31, 2015 by $63.7 million. During 2015, the Company made payments to the IRS of $61.0 million for federal tax payments and associated interest related to the matter. The November 2016 Fifth Circuit decision to remand the case back to the Tax Court did not change the Company’s assessment regarding the likelihood of whether these deductions would ultimately be sustained. Accordingly, no change in the valuation allowance was made as of March 31, 2020. |
Earnings per Common Share
Earnings per Common Share | 3 Months Ended |
Mar. 31, 2020 | |
Earnings Per Share [Abstract] | |
Earnings per Common Share | Earnings per Common Share For all periods in which they are outstanding, the Series D Participating Convertible Preferred Stock (the "D Stock") and the second lien warrants are included in the weighted-average number of common shares outstanding utilized to calculate basic earnings per common share because the D Stock is deemed a common stock equivalent and the second lien warrants are considered outstanding common shares. The following table summarizes the weighted-average share amounts used in calculating loss per share: Three Months Ended March 31, (Amounts in millions) 2020 2019 Basic and diluted common shares outstanding 77.4 64.8 Potential common shares issuable to employees upon exercise or conversion of shares under the Company's stock-based compensation plans and upon exercise of the Ripple Warrants (as defined below) are excluded from the computation of diluted earnings per common share when the effect would be anti-dilutive. All potential common shares are anti-dilutive in periods of net loss available to common stockholders. Stock options are anti-dilutive when the exercise price of these instruments is greater than the average market price of the Company’s common stock for the period, regardless of whether the Company is in a period of net loss available to common shareholders. The following table summarizes the weighted-average potential common shares excluded from diluted loss per common share as their effect would be anti-dilutive: Three Months Ended March 31, (Amounts in millions) 2020 2019 Shares related to stock options 0.4 1.3 Shares related to restricted stock units 2.8 2.5 Shares related to warrants 6.0 — Shares excluded from the computation 9.2 3.8 |
Segment Information
Segment Information | 3 Months Ended |
Mar. 31, 2020 | |
Segment Reporting [Abstract] | |
Segment Information | Segment Information The Company’s reporting segments are primarily organized based on the nature of products and services offered and the type of consumer served. The Company has two reporting segments: Global Funds Transfer and Financial Paper Products. See Note 1 — Description of the Business and Basis of Presentation for further discussion on our segments. Walmart Inc. ("Walmart") is our only agent, for both the Global Funds Transfer segment and the Financial Paper Products segment, that accounts for more than 10% of total revenue. For the three months ended March 31, 2020 and 2019, Walmart accounted for 14% and 16%, respectively, of total revenue. The following table is a summary of the total revenue by segment: Three Months Ended (Amounts in millions) 2020 2019 Global Funds Transfer revenue Money transfer revenue $ 255.9 $ 273.3 Bill payment revenue 13.4 15.9 Total Global Funds Transfer revenue 269.3 289.2 Financial Paper Products revenue Money order revenue 12.1 13.9 Official check revenue 9.5 12.3 Total Financial Paper Products revenue 21.6 26.2 Total revenue $ 290.9 $ 315.4 The following table is a summary of the operating income by segment and detail of the (loss) income before income taxes: Three Months Ended (Amounts in millions) 2020 2019 Global Funds Transfer operating income $ 6.7 $ 1.1 Financial Paper Products operating income 7.0 8.2 Total segment operating income 13.7 9.3 Other operating loss (0.6) (0.7) Total operating income 13.1 8.6 Interest expense 23.8 13.9 Other non-operating expense 1.1 1.6 Loss before income taxes $ (11.8) $ (6.9) The following table sets forth assets by segment: (Amounts in millions) March 31, 2020 December 31, 2019 Global Funds Transfer $ 1,259.4 $ 1,318.3 Financial Paper Products 2,581.5 2,819.1 Other 54.8 47.6 Total assets $ 3,895.7 $ 4,185.0 |
Revenue Recognition
Revenue Recognition | 3 Months Ended |
Mar. 31, 2020 | |
Revenue from Contract with Customer [Abstract] | |
Revenue Recognition | Revenue Recognition The following table is a summary of the Company's revenue streams disaggregated by services and products for each segment and timing of revenue recognition for such services and products excluding other revenue: Three Months Ended March 31, (Amounts in millions) 2020 2019 Global Funds Transfer revenue Money transfer fee revenue $ 251.5 $ 269.9 Bill payment services fee revenue 13.4 15.9 Other revenue 4.4 3.4 Total Global Funds Transfer fee and other revenue 269.3 289.2 Financial Paper Products revenue Money order fee revenue 2.0 2.3 Official check outsourcing services fee revenue 2.0 2.1 Other revenue 7.5 7.4 Total Financial Paper Products fee and other revenue 11.5 11.8 Investment revenue 10.1 14.4 Total revenue $ 290.9 $ 315.4 Timing of revenue recognition: Services and products transferred at a point in time $ 266.9 $ 288.1 Products transferred over time 2.0 2.1 Total revenue from services and products 268.9 290.2 Investment revenue 10.1 14.4 Other revenue 11.9 10.8 Total revenue $ 290.9 $ 315.4 Due to the short-term nature of the Company's services and products, the amount of contract assets and liabilities on the Condensed Consolidated Balance Sheets as of March 31, 2020 and December 31, 2019, is negligible. Assets for unsettled money transfers, money orders and consumer payments are included in "Settlement assets" with a corresponding liability recorded in "Payment service obligations" on the Condensed Consolidated Balance Sheets. For more information on these assets and liabilities see Note 3 — Settlement Assets and Payment Service Obligations |
Related Party Disclosures
Related Party Disclosures | 3 Months Ended |
Mar. 31, 2020 | |
Related Party Transactions [Abstract] | |
Related Party Transactions Disclosure | In June 2019, the Company entered into a multiple element arrangement with Ripple Labs Inc. ("Ripple") consisting of two contracts: a securities purchase agreement (the “SPA”) and a commercial agreement. Pursuant to the SPA, the Company issued and sold to Ripple an aggregate of 6,237,523 shares of common stock and warrants to purchase 5,957,600 shares of common stock (“Ripple Warrants”) pursuant to separate issuances of common stock and Ripple Warrants, one in June 2019 and another in November 2019. Through the commercial agreement, which is scheduled to expire on July 1, 2023, we utilize Ripple’s On Demand Liquidity ("ODL") platform (formerly known as xRapid), as well as XRP, to facilitate cross-border non-U.S. dollar exchange settlements. Related party transactions are not necessarily indicative of an arm’s length transaction or comparable to a transaction that had been entered into with independent parties. The “Transaction and operations support” line on the Condensed Consolidated Statements of Operations includes market development fees of $16.6 million for the three months ended March 31, 2020. As of March 31, 2020, the “Other assets” line in the Condensed Consolidated Balance Sheets included accounts receivable and a cryptocurrency indefinite-lived intangible asset of $0.9 million and $3.1 million, respectively. |
Description of the Business a_2
Description of the Business and Basis of Presentation (Policies) | 3 Months Ended |
Mar. 31, 2020 | |
Description of the Business and Basis of Presentation [Abstract] | |
Basis of Presentation | Basis of Presentation — The accompanying unaudited condensed consolidated financial statements of MoneyGram are prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. The Condensed Consolidated Balance Sheets are unclassified due to the timing uncertainty surrounding the payment of settlement obligations. |
Use of Estimates | Use of Estimates — The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates and assumptions are based on historical experience, future expectations and other factors and assumptions the Company believes to be reasonable under the circumstances. These estimates and assumptions are reviewed on an ongoing basis and are revised when necessary. Changes in estimates are recorded in the period of change. Actual amounts may differ from these estimates. |
Recent Accounting Pronouncements and Related Developments | Recent Accounting Pronouncements and Related Developmen ts — In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . The new credit impairment standard changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, entities will be required to use a new forward-looking expected loss model that generally will result in the earlier recognition of allowances for credit losses. For available-for-sale debt securities with unrealized losses, entities will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. To further assist with adoption and implementation of ASU 2016-13, the FASB issued the following ASUs: • ASU 2018-19 (Issued November 2018) — Codification Improvements to Topic 326, Financial Instruments - Credit Losses • ASU 2019-04 (Issued April 2019) — Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments • ASU 2019-05 (Issued May 2019) — Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief • ASU 2019-10 (Issued November 2019) — Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates • ASU 2019-11 (Issued November 2019) — Codification Improvements to Topic 326, Financial Instruments - Credit Losses • ASU 2020-02 (Issued February 2020) — Financial Instruments - Credit Losses (Topic 326) and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842) (SEC Update) • ASU 2020-03 (Issued March 2020) — Codification Improvements to Financial Instruments ASU 2019-10 changed the effective date of ASU 2016-13 for public business entities that meet the definition of a Securities and Exchange Commission ("SEC") filer but that are eligible to be a smaller reporting company to fiscal years beginning after December 15, 2022. MoneyGram is a smaller reporting company and, as such, will adopt the amendments in these standards in 2023. We are still evaluating these ASUs, but we do not believe the adoption will have a material impact on our consolidated financial statements. In August 2018, the FASB issued ASU 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefits Plans. The amendments in this standard require that entities now disclose the weighted-average interest credit ratings for cash balance plans and other plans with promised interest credit ratings and an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period, as well as clarify and remove certain other disclosures. This standard is effective for fiscal years ending after December 15, 2020, and, as such, its disclosure requirements will be reflected in the 2020 Annual Report on Form 10-K. This standard does not impact our consolidated financial statements. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting . The amendments in this ASU provide, if certain criteria are met, optional expedients and exceptions for applying the GAAP requirements for contract modifications, hedging relationships and sales or transfers of debt securities, that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform through December 31, 2022. The adoption of this ASU is optional and the election can be made anytime during the effective period. The amendments in this ASU are effective as of March 12, 2020 through December 31, 2022. MoneyGram is currently evaluating the impact of this standard and has not yet determined whether we will elect the optional expedients. The Company has determined that there have been no other recently adopted or issued accounting standards that had, or will have, a material impact on its condensed consolidated financial statements. |
Restructuring and Reorganizat_2
Restructuring and Reorganization Costs (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Restructuring and Reorganization Costs [Abstract] | |
Schedule of restructuring and reorganization costs accrual | The following table is a roll-forward of the reorganization costs accrual as of March 31, 2020: (Amounts in millions) 2019 Organizational Realignment Balance, December 31, 2019 $ 4.6 Expenses 0.7 Cash payments (4.6) Balance, March 31, 2020 $ 0.7 |
Summary of cumulative restructuring and reorganization costs incurred | The following table is a summary of the cumulative reorganization costs incurred to date in operating expenses as of March 31, 2020: |
Summary of total cumulative restructuring and reorganization costs incurred by reporting segment | (Amounts in millions) 2019 Organizational Realignment Balance, December 31, 2019 $ 6.8 First quarter 2020 0.7 Total cumulative reorganization costs incurred to date $ 7.5 |
Settlement Assets and Payment_2
Settlement Assets and Payment Service Obligations (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Summary of settlement assets and payment service obligations | The following table summarizes the amount of settlement assets and payment service obligations: (Amounts in millions) March 31, 2020 December 31, 2019 Settlement assets: Settlement cash and cash equivalents $ 1,371.6 $ 1,531.1 Receivables, net 579.5 715.5 Interest-bearing investments 989.1 985.9 Available-for-sale investments 4.3 4.5 $ 2,944.5 $ 3,237.0 Payment service obligations $ (2,944.5) $ (3,237.0) |
Fair Value Measurement (Tables)
Fair Value Measurement (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Fair Value Disclosures [Abstract] | |
Financial assets measured at fair value by hierarchy level | The following table summarizes the Company’s financial assets and liabilities measured at fair value by hierarchy level on a recurring basis: (Amounts in millions) Level 2 Level 3 Total March 31, 2020 Financial assets: Available-for-sale investments: Residential mortgage-backed securities $ 3.5 $ — $ 3.5 Asset-backed and other securities — 0.8 0.8 Forward contracts 4.3 — 4.3 Total financial assets $ 7.8 $ 0.8 $ 8.6 Financial liabilities: Forward contracts $ — $ — $ — December 31, 2019 Financial assets: Available-for-sale investments: Residential mortgage-backed securities $ 3.6 $ — $ 3.6 Asset-backed and other securities — 0.9 0.9 Forward contracts — — — Total financial assets $ 3.6 $ 0.9 $ 4.5 Financial liabilities: Forward contracts $ 0.8 $ — $ 0.8 |
Investment Portfolio (Tables)
Investment Portfolio (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Investments [Abstract] | |
Components of investment portfolio | The following table shows the components of the investment portfolio: (Amounts in millions) March 31, 2020 December 31, 2019 Cash $ 1,500.1 $ 1,675.4 Money market securities 2.5 2.5 Cash and cash equivalents (1) 1,502.6 1,677.9 Interest-bearing investments 989.1 985.9 Available-for-sale investments 4.3 4.5 Total investment portfolio $ 2,496.0 $ 2,668.3 (1) For purposes of the disclosure of the investment portfolio as a whole, the cash and cash equivalents balance includes settlement cash and cash equivalents. |
Available for sale Investments (substantially restricted) | The following table is a summary of the amortized cost and fair value of available-for-sale investments: (Amounts in millions) Amortized Gross Fair March 31, 2020 Residential mortgage-backed securities $ 3.1 $ 0.4 $ 3.5 Asset-backed and other securities 0.2 0.6 0.8 Total $ 3.3 $ 1.0 $ 4.3 December 31, 2019 Residential mortgage-backed securities $ 3.3 $ 0.3 $ 3.6 Asset-backed and other securities 0.2 0.7 0.9 Total $ 3.5 $ 1.0 $ 4.5 |
Derivative Financial Instrume_2
Derivative Financial Instruments (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Derivative Instrument Detail [Abstract] | |
Summary of gains (losses) related to assets and liabilities denominated in foreign currencies | The following net (losses) gains related to assets and liabilities denominated in non-U.S. dollar are included in “Transaction and operations support” in the Condensed Consolidated Statements of Operations and in the "Net cash provided by operating activities" line in the Condensed Consolidated Statements of Cash Flows: Three Months Ended March 31, (Amounts in millions) 2020 2019 Net realized non-U.S. dollar loss $ (3.8) $ (3.5) Net gain from the related forward contracts 6.3 5.1 Net gain from non-U.S. dollar transactions and related forward contracts $ 2.5 $ 1.6 |
Fair values of derivative forward contract instruments | As of March 31, 2020 and December 31, 2019, the Company reflects the following fair values of derivative forward contract instruments in its Condensed Consolidated Balance Sheets: Gross Amount of Recognized Assets Gross Amount of Offset Net Amount of Assets Presented in the Consolidated Balance Sheets (Amounts in millions) Balance Sheet Location March 31, 2020 December 31, 2019 March 31, 2020 December 31, 2019 March 31, 2020 December 31, 2019 Forward contracts Other assets $ 4.8 $ 0.2 $ (0.5) $ (0.2) $ 4.3 $ — Gross Amount of Recognized Liabilities Gross Amount of Offset Net Amount of Liabilities Presented in the Consolidated Balance Sheets (Amounts in millions) Balance Sheet Location March 31, 2020 December 31, 2019 March 31, 2020 December 31, 2019 March 31, 2020 December 31, 2019 Forward contracts Accounts payable and other liabilities $ 0.5 $ 1.0 $ (0.5) $ (0.2) $ — $ 0.8 |
Debt (Tables)
Debt (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Debt Disclosure [Abstract] | |
Summary of outstanding debt | The following is a summary of the Company's outstanding debt: (Amounts in millions, except percentages) March 31, 2020 December 31, 2019 6.95% first lien revolving credit facility due 2022 $ 23.0 $ — 7.00% first lien credit facility due 2023 640.2 641.8 13.00% second lien credit facility due 2024 254.6 251.4 Senior secured credit facilities 917.8 893.2 Unamortized debt issuance costs and debt discounts (40.3) (42.9) Total debt, net $ 877.5 $ 850.3 |
Credit agreement quarterly financial covenants | The table below summarizes the interest coverage, first lien and total leverage ratio covenants, which are calculated based on the four-fiscal quarter period ending on each quarter end beginning September 30, 2019 through the maturity of the First Lien Credit Facility: Interest Coverage Minimum Ratio First Lien Leverage Ratio Not to Exceed Total Leverage Ratio Not to Exceed July 1, 2019 through June 30, 2020 2.50:1 3.750:1 5.125:1 July 1, 2020 through December 31, 2020 2.50:1 3.500:1 5.000:1 January 1, 2021 through maturity 2.50:1 3.000:1 4.500:1 |
Pension and Other Benefits (Tab
Pension and Other Benefits (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Retirement Benefits [Abstract] | |
Schedule of net periodic benefit expense (income) | The following table is a summary of net periodic benefit expense for the Company's defined benefit pension plan and supplemental executive retirement plans, collectively referred to as "Pension": Three Months Ended March 31, (Amounts in millions) 2020 2019 Interest cost $ 0.8 $ 1.7 Expected return on plan assets (0.2) (1.1) Amortization of net actuarial loss 0.5 0.9 Net periodic benefit expense $ 1.1 $ 1.5 |
Pension and Other Benefits | Pension and Other Benefits The following table is a summary of net periodic benefit expense for the Company's defined benefit pension plan and supplemental executive retirement plans, collectively referred to as "Pension": Three Months Ended March 31, (Amounts in millions) 2020 2019 Interest cost $ 0.8 $ 1.7 Expected return on plan assets (0.2) (1.1) Amortization of net actuarial loss 0.5 0.9 Net periodic benefit expense $ 1.1 $ 1.5 The Company had nominal net |
Stockholders' Deficit (Tables)
Stockholders' Deficit (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Stockholders' Equity Note [Abstract] | |
Summary of significant amounts reclassified | The following table is a summary of the significant amounts reclassified out of each component of "Accumulated other comprehensive loss": Three Months Ended (Amounts in millions) 2020 2019 Statement of Operations Location Pension and Postretirement Benefits adjustments: Amortization of net actuarial loss $ 0.5 $ 0.9 "Other non-operating expense" Total before tax 0.5 0.9 Tax benefit, net (0.1) (0.1) Total reclassified for the period, net of tax $ 0.4 $ 0.8 |
Summary of changes to accumulated other comprehensive loss by compenent | The following table is a summary of the changes to Accumulated other comprehensive loss by component: (Amounts in millions) Net Unrealized Gains on Securities Classified as Available-for-sale, Net of Tax Cumulative non-U.S. dollar Translation Adjustments, Net of Tax Pension and Postretirement Benefits Adjustment, Net of Tax Total January 1, 2020 $ 1.6 $ (28.1) $ (37.0) $ (63.5) Other comprehensive loss before reclassification — (7.2) — (7.2) Amounts reclassified from accumulated other comprehensive loss — — 0.4 0.4 Net current period other comprehensive (loss) income — (7.2) 0.4 (6.8) March 31, 2020 $ 1.6 $ (35.3) $ (36.6) $ (70.3) (Amounts in millions) Net Unrealized Gains on Securities Classified as Available-for-sale, Net of Tax Cumulative non-U.S. dollar Translation Adjustments, Net of Tax Pension and Postretirement Benefits Adjustment, Net of Tax Total January 1, 2019 $ 1.9 $ (24.2) $ (45.2) $ (67.5) Adoption of 2018-02 ASU — (3.7) (11.4) (15.1) Other comprehensive income (loss) before reclassification 0.2 (3.1) — (2.9) Amounts reclassified from accumulated other comprehensive loss — — 0.8 0.8 Net current period other comprehensive income (loss) 0.2 (3.1) 0.8 (2.1) March 31, 2019 $ 2.1 $ (31.0) $ (55.8) $ (84.7) |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Summary of stock-based compensation expense | The following table is a summary of the Company's stock-based compensation expense: Three Months Ended March 31, (Amounts in millions) 2020 2019 Stock-based compensation expense $ 2.0 $ 2.6 |
Summary of stock option activity | The following table is a summary of the Company’s stock option activity: Shares Weighted- Weighted- Aggregate Options outstanding at December 31, 2019 409,296 $ 19.34 2.4 years $ — Forfeited/Expired (22,081) 20.65 Options outstanding, vested or expected to vest, and exercisable at March 31, 2020 387,215 $ 19.27 2.1 years $ — |
Summary of restricted stock unit activity | The following table is a summary of the Company’s restricted stock unit activity: Total Weighted-Average Grant-Date Fair Value Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value ($000,000) Restricted stock units outstanding at December 31, 2019 2,731,758 $ 5.02 0.9 years $ 5.7 Granted 3,199,294 2.12 Vested and converted to shares (997,868) 6.90 Forfeited (99,042) 3.73 Restricted stock units outstanding at March 31, 2020 4,834,142 $ 2.74 1.6 years $ 6.3 Restricted stock units vested and deferred at March 31, 2020 54,472 $ 8.26 $ 0.1 |
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity | The following table is a summary of the Company's restricted stock unit compensation information: Three Months Ended March 31, (Amounts in millions) 2020 2019 Weighted-average grant-date fair value of restricted stock units vested during the period $ 6.9 $ 8.9 Total intrinsic value of vested and converted shares $ 2.5 $ 2.5 |
Earnings per Common Share (Tabl
Earnings per Common Share (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following table summarizes the weighted-average share amounts used in calculating loss per share: Three Months Ended March 31, (Amounts in millions) 2020 2019 Basic and diluted common shares outstanding 77.4 64.8 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The following table summarizes the weighted-average potential common shares excluded from diluted loss per common share as their effect would be anti-dilutive: Three Months Ended March 31, (Amounts in millions) 2020 2019 Shares related to stock options 0.4 1.3 Shares related to restricted stock units 2.8 2.5 Shares related to warrants 6.0 — Shares excluded from the computation 9.2 3.8 |
Segment Information (Tables)
Segment Information (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Segment Reporting [Abstract] | |
Revenue by segment | The following table is a summary of the total revenue by segment: Three Months Ended (Amounts in millions) 2020 2019 Global Funds Transfer revenue Money transfer revenue $ 255.9 $ 273.3 Bill payment revenue 13.4 15.9 Total Global Funds Transfer revenue 269.3 289.2 Financial Paper Products revenue Money order revenue 12.1 13.9 Official check revenue 9.5 12.3 Total Financial Paper Products revenue 21.6 26.2 Total revenue $ 290.9 $ 315.4 |
Operating income by segment | The following table is a summary of the operating income by segment and detail of the (loss) income before income taxes: Three Months Ended (Amounts in millions) 2020 2019 Global Funds Transfer operating income $ 6.7 $ 1.1 Financial Paper Products operating income 7.0 8.2 Total segment operating income 13.7 9.3 Other operating loss (0.6) (0.7) Total operating income 13.1 8.6 Interest expense 23.8 13.9 Other non-operating expense 1.1 1.6 Loss before income taxes $ (11.8) $ (6.9) |
Assets by Segment | The following table sets forth assets by segment: (Amounts in millions) March 31, 2020 December 31, 2019 Global Funds Transfer $ 1,259.4 $ 1,318.3 Financial Paper Products 2,581.5 2,819.1 Other 54.8 47.6 Total assets $ 3,895.7 $ 4,185.0 |
Revenue Recognition (Tables)
Revenue Recognition (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Revenue from Contract with Customer [Abstract] | |
Summary of Revenue Streams | The following table is a summary of the Company's revenue streams disaggregated by services and products for each segment and timing of revenue recognition for such services and products excluding other revenue: Three Months Ended March 31, (Amounts in millions) 2020 2019 Global Funds Transfer revenue Money transfer fee revenue $ 251.5 $ 269.9 Bill payment services fee revenue 13.4 15.9 Other revenue 4.4 3.4 Total Global Funds Transfer fee and other revenue 269.3 289.2 Financial Paper Products revenue Money order fee revenue 2.0 2.3 Official check outsourcing services fee revenue 2.0 2.1 Other revenue 7.5 7.4 Total Financial Paper Products fee and other revenue 11.5 11.8 Investment revenue 10.1 14.4 Total revenue $ 290.9 $ 315.4 Timing of revenue recognition: Services and products transferred at a point in time $ 266.9 $ 288.1 Products transferred over time 2.0 2.1 Total revenue from services and products 268.9 290.2 Investment revenue 10.1 14.4 Other revenue 11.9 10.8 Total revenue $ 290.9 $ 315.4 |
Description of the Business a_3
Description of the Business and Basis of Presentation (Details) $ in Millions | 3 Months Ended | |
Mar. 31, 2020USD ($)segment | Dec. 31, 2019USD ($) | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Number of reportable segments | segment | 2 | |
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | $ 10.6 | |
Deferred Tax Assets, Valuation Allowance | $ 10.1 |
Restructuring and Reorganizat_3
Restructuring and Reorganization Costs - Schedule of Restructuring and Reorganization Costs Accrual (Details) - mgi_A2019ReorganizationalRealignmentMember $ in Millions | 3 Months Ended |
Mar. 31, 2020USD ($) | |
Restructuring Reserve [Roll Forward] | |
Beginning balance | $ 4.6 |
Expenses | 0.7 |
Cash payments | (4.6) |
Ending balance | $ 0.7 |
Restructuring and Reorganizat_4
Restructuring and Reorganization Costs - Summary of Total Cumulative Restructuring and Reorganization Costs Incurred By Reporting Segment (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended |
Mar. 31, 2020 | Dec. 31, 2019 | |
Restructuring Cost and Reserve [Line Items] | ||
mgi_OrganizationalRealignmentItems | $ 0.7 | $ 6.8 |
Other Restructuring | Global Funds Transfer | ||
Restructuring Cost and Reserve [Line Items] | ||
mgi_OrganizationalRealignmentCostIncurredCost | $ 7.5 |
Settlement Assets and Payment_3
Settlement Assets and Payment Service Obligations - Summary of Settlement Assets and Payment Service Obligations (Details) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | ||
Settlement cash and cash equivalents | $ 1,371.6 | $ 1,531.1 |
Receivables, net | 579.5 | 715.5 |
Interest-bearing investments | 989.1 | 985.9 |
Available-for-sale investments | 4.3 | 4.5 |
Settlement assets | 2,944.5 | 3,237 |
Payment service obligations | $ (2,944.5) | $ (3,237) |
Fair Value Measurement - Financ
Fair Value Measurement - Financial Assets and Liabilities Measured at Fair Value by Hierarchy Level (Detail) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Financial assets: | ||
Available-for-sale investments: | $ 4.3 | $ 4.5 |
Financial liabilities: | ||
Senior secured credit facilities | 917.8 | 893.2 |
Fair Value, Measurements, Recurring | ||
Financial assets: | ||
Total financial assets | 8.6 | 4.5 |
Fair Value, Measurements, Nonrecurring | Second Lien Credit Facility due 2024 [Member] | ||
Financial liabilities: | ||
Fair value of credit facility | 185.7 | 236.7 |
Residential mortgage-backed securities — agencies | Fair Value, Measurements, Recurring | ||
Financial assets: | ||
Available-for-sale investments: | 3.5 | 3.6 |
Asset-backed and other securities | ||
Financial assets: | ||
Available-for-sale investments: | 0.8 | 0.9 |
Asset-backed and other securities | Fair Value, Measurements, Recurring | ||
Financial assets: | ||
Available-for-sale investments: | 0.8 | 0.9 |
Forward contracts | Fair Value, Measurements, Recurring | ||
Financial assets: | ||
Forward contracts | 4.3 | 0 |
Financial liabilities: | ||
Forward contracts | 0 | 0.8 |
Level 2 | mgi_FirstLienCreditFacilitydue2023Member [Member] | ||
Financial liabilities: | ||
Senior secured credit facilities | 640.2 | 641.8 |
Level 2 | Fair Value, Measurements, Recurring | ||
Financial assets: | ||
Total financial assets | 7.8 | 3.6 |
Level 2 | Fair Value, Measurements, Nonrecurring | ||
Financial liabilities: | ||
Fair value of credit facility | 460.9 | 577.6 |
Level 2 | Residential mortgage-backed securities — agencies | Fair Value, Measurements, Recurring | ||
Financial assets: | ||
Available-for-sale investments: | 3.5 | 3.6 |
Level 2 | Asset-backed and other securities | Fair Value, Measurements, Recurring | ||
Financial assets: | ||
Available-for-sale investments: | 0 | 0 |
Level 2 | Forward contracts | Fair Value, Measurements, Recurring | ||
Financial assets: | ||
Forward contracts | 4.3 | 0 |
Financial liabilities: | ||
Forward contracts | 0 | 0.8 |
Level 3 | Second Lien Credit Facility due 2024 [Member] | ||
Financial liabilities: | ||
Senior secured credit facilities | 254.6 | 251.4 |
Level 3 | Fair Value, Measurements, Recurring | ||
Financial assets: | ||
Total financial assets | 0.8 | 0.9 |
Level 3 | Residential mortgage-backed securities — agencies | Fair Value, Measurements, Recurring | ||
Financial assets: | ||
Available-for-sale investments: | 0 | 0 |
Level 3 | Asset-backed and other securities | Fair Value, Measurements, Recurring | ||
Financial assets: | ||
Available-for-sale investments: | 0.8 | 0.9 |
Level 3 | Forward contracts | Fair Value, Measurements, Recurring | ||
Financial assets: | ||
Forward contracts | 0 | 0 |
Financial liabilities: | ||
Forward contracts | $ 0 | $ 0 |
Fair Value Measurement - Fair V
Fair Value Measurement - Fair Value and Carrying Value of Debt (Detail) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Senior secured credit facilities | $ 917.8 | $ 893.2 |
mgi_FirstLienCreditFacilitydue2023Member [Member] | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Senior secured credit facilities | 640.2 | 641.8 |
Second Lien Credit Facility due 2024 [Member] | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Senior secured credit facilities | $ 254.6 | $ 251.4 |
Investment Portfolio - Componen
Investment Portfolio - Components of Investment Portfolio (Details) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Cash and Cash Equivalents [Line Items] | ||
Cash | $ 1,500.1 | $ 1,675.4 |
Money market securities | 2.5 | 2.5 |
Interest-bearing investments | 989.1 | 985.9 |
Available-for-sale investments | 4.3 | 4.5 |
Total investment portfolio | 2,496 | 2,668.3 |
Cash and cash equivalents | ||
Cash and Cash Equivalents [Line Items] | ||
Cash and cash equivalents | $ 1,502.6 | $ 1,677.9 |
Investment Portfolio - Availabl
Investment Portfolio - Available for Sale Investments (Substantially Restricted) (Details) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale Securities, Amortized Cost Basis, Total | $ 3.3 | $ 3.5 |
Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | 1 | 1 |
Available-for-sale Securities | 4.3 | 4.5 |
Asset-backed and other securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale Securities, Amortized Cost Basis, Total | 0.2 | 0.2 |
Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | 0.6 | 0.7 |
Available-for-sale Securities | 0.8 | 0.9 |
Residential Mortgage Backed Securities [Member] | ||
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale Securities, Amortized Cost Basis, Total | 3.1 | 3.3 |
Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | 0.4 | 0.3 |
Available-for-sale Securities | $ 3.5 | $ 3.6 |
Investment Portfolio - Addition
Investment Portfolio - Additional Information (Details) | Mar. 31, 2020 | Dec. 31, 2019 |
Investments [Abstract] | ||
Percentage of available-for-sale investments collateralized by US government agency debentures | 81.00% | 80.00% |
Derivative Financial Instrume_3
Derivative Financial Instruments - Additional Information (Detail) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Not Designated as Hedging Instrument | Foreign Exchange Forward | ||
Derivatives, Fair Value [Line Items] | ||
Forward contracts outstanding notional amount | $ 389.4 | $ 349.1 |
Derivative Financial Instrume_4
Derivative Financial Instruments - Summary of (Gains) Losses Related to Assets and Liabilities Denominated in Foreign Currencies (Detail) - Transaction and operations support - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Derivative Instruments, Gain (Loss) [Line Items] | ||
Net realized non-U.S. dollar loss | $ (3.8) | $ (3.5) |
Net gain from the related forward contracts | 6.3 | 5.1 |
Net gain from non-U.S. dollar transactions and related forward contracts | $ 2.5 | $ 1.6 |
Derivative Financial Instrume_5
Derivative Financial Instruments - Fair Values of Derivative Forward Contract Instruments (Detail) - Foreign Exchange Forward - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Other assets | ||
Derivatives, Fair Value [Line Items] | ||
Gross Amount of Recognized Assets | $ 4.8 | $ 0.2 |
Gross Amount of Offset | (0.5) | (0.2) |
Net Amount of Assets Presented in the Consolidated Balance Sheets | 4.3 | 0 |
Accounts payable and other liabilities | ||
Derivatives, Fair Value [Line Items] | ||
Gross Amount of Recognized Liabilities | 0.5 | 1 |
Gross Amount of Offset | (0.5) | (0.2) |
Net Amount of Liabilities Presented in the Consolidated Balance Sheets | $ 0 | $ 0.8 |
Debt - Additional Information (
Debt - Additional Information (Detail) $ in Millions | Mar. 31, 2020USD ($) | Dec. 31, 2019USD ($)shares | Jun. 26, 2019USD ($) |
Debt Instrument [Line Items] | |||
Class of Warrant or Right, Outstanding | shares | 5,957,600 | ||
Assets In excess of payment service obligations | $ 131 | $ 146.8 | |
Interest Coverage Minimum Ratio | 3.374 | ||
First Lien Leverage Ratio Not to Exceed | 2.900 | ||
Total Leverage Ratio Not to Exceed | 4.013 | ||
First Lien Credit Facility due 2023 [Member] | |||
Debt Instrument [Line Items] | |||
Debt Instrument, Face Amount | $ 640.2 | 641.8 | $ 645 |
Effective interest rate | 8.33% | ||
Term Credit Facility [Member] | |||
Debt Instrument [Line Items] | |||
Debt Instrument, Face Amount | $ 23 | $ 0 | |
Effective interest rate | 6.95% | ||
Revolving Credit Facility [Member] | |||
Debt Instrument [Line Items] | |||
Long-term line of credit | 35 | ||
Second Lien Credit Facility due 2024 [Member] | |||
Debt Instrument [Line Items] | |||
Debt Instrument, Face Amount | $ 254.6 | $ 251.4 | $ 245 |
Effective interest rate | 13.00% | ||
July 1, 2019 through June 30, 2020 | |||
Debt Instrument [Line Items] | |||
Interest Coverage Minimum Ratio | 2.500 | ||
First Lien Leverage Ratio Not to Exceed | 3.750 | ||
Total Leverage Ratio Not to Exceed | 5.125 | ||
July 1, 2020 through December 31, 2020 | |||
Debt Instrument [Line Items] | |||
Interest Coverage Minimum Ratio | 2.500 | ||
First Lien Leverage Ratio Not to Exceed | 3.500 | ||
Total Leverage Ratio Not to Exceed | 5 | ||
January 1, 2021 through maturity | |||
Debt Instrument [Line Items] | |||
Interest Coverage Minimum Ratio | 2.500 | ||
First Lien Leverage Ratio Not to Exceed | 3 | ||
Total Leverage Ratio Not to Exceed | 4.500 |
Debt - Outstanding Debt (Detail
Debt - Outstanding Debt (Details) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 | Jun. 26, 2019 |
Debt Instrument [Line Items] | |||
Interest Coverage Minimum Ratio | 3.374 | ||
First Lien Leverage Ratio Not to Exceed | 2.900 | ||
Total Leverage Ratio Not to Exceed | 4.013 | ||
Senior secured credit facilities | $ 917.8 | $ 893.2 | |
Unamortized debt issuance costs and debt discounts | (40.3) | (42.9) | |
Total debt, net | 877.5 | 850.3 | |
Term Credit Facility [Member] | |||
Debt Instrument [Line Items] | |||
Debt Instrument, Face Amount | 23 | $ 0 | |
Effective Interest Rate | 6.95% | ||
First Lien Credit Facility due 2023 [Member] | |||
Debt Instrument [Line Items] | |||
Debt Instrument, Face Amount | $ 640.2 | $ 641.8 | $ 645 |
Effective Interest Rate | 8.33% | ||
Second Lien Credit Facility due 2024 [Member] | |||
Debt Instrument [Line Items] | |||
Debt Instrument, Face Amount | $ 254.6 | $ 251.4 | $ 245 |
Effective Interest Rate | 13.00% |
Pension and Other Benefits - Ne
Pension and Other Benefits - Net Periodic Benefit Expense Amortized from Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Retirement Benefits [Abstract] | ||
Interest cost | $ 0.8 | $ 1.7 |
Expected return on plan assets | (0.2) | (1.1) |
Amortization of net actuarial loss | 0.5 | 0.9 |
Net periodic benefit expense | $ 1.1 | $ 1.5 |
Stockholders' Deficit - Additio
Stockholders' Deficit - Additional Information (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Class of Stock [Line Items] | ||
Dividends paid | $ 0 | $ 0 |
Stockholders' Deficit - Summary
Stockholders' Deficit - Summary of Significant Amounts Reclassified (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Tax benefit, net | $ 0 | $ 0 |
Pension and Postretirement Benefits Adjustment, Net of Tax | Reclassification out of Accumulated Other Comprehensive Income | ||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Amortization of net actuarial loss | 0.5 | 0.9 |
Total before tax | 0.5 | 0.9 |
Tax benefit, net | (0.1) | (0.1) |
Total reclassified for the period, net of tax | $ 0.4 | $ 0.8 |
Stockholders' Deficit - Summa_2
Stockholders' Deficit - Summary of Changes To Accumulated Other Comprehensive Loss By Compenent (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Roll Forward] | ||
Beginning balance | $ (63.5) | |
Net current period other comprehensive income (loss) | (6.8) | $ (2.1) |
Ending balance | (70.3) | |
Net Unrealized Gains on Securities Classified as Available-for-sale, Net of Tax | ||
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Roll Forward] | ||
Beginning balance | 1.6 | 1.9 |
Other comprehensive loss before reclassification | 0 | 0.2 |
Amounts reclassified from accumulated other comprehensive loss | 0 | 0 |
Net current period other comprehensive income (loss) | 0 | 0.2 |
Ending balance | 1.6 | 2.1 |
Net Unrealized Gains on Securities Classified as Available-for-sale, Net of Tax | Cumulative effect of adoption of ASU 2018-02 | ||
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Roll Forward] | ||
Beginning balance | 0 | |
Cumulative non-U.S. dollar Translation Adjustments, Net of Tax | ||
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Roll Forward] | ||
Beginning balance | (28.1) | (24.2) |
Other comprehensive loss before reclassification | (7.2) | (3.1) |
Amounts reclassified from accumulated other comprehensive loss | 0 | 0 |
Net current period other comprehensive income (loss) | (7.2) | (3.1) |
Ending balance | (35.3) | (31) |
Cumulative non-U.S. dollar Translation Adjustments, Net of Tax | Cumulative effect of adoption of ASU 2018-02 | ||
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Roll Forward] | ||
Beginning balance | (3.7) | |
Pension and Postretirement Benefits Adjustment, Net of Tax | ||
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Roll Forward] | ||
Beginning balance | (37) | (45.2) |
Other comprehensive loss before reclassification | 0 | 0 |
Amounts reclassified from accumulated other comprehensive loss | 0.4 | 0.8 |
Net current period other comprehensive income (loss) | 0.4 | 0.8 |
Ending balance | (36.6) | (55.8) |
Pension and Postretirement Benefits Adjustment, Net of Tax | Cumulative effect of adoption of ASU 2018-02 | ||
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Roll Forward] | ||
Beginning balance | (11.4) | |
Accumulated Other Comprehensive Loss | ||
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Roll Forward] | ||
Beginning balance | (63.5) | (67.5) |
Other comprehensive loss before reclassification | (7.2) | (2.9) |
Amounts reclassified from accumulated other comprehensive loss | 0.4 | 0.8 |
Net current period other comprehensive income (loss) | (6.8) | (2.1) |
Ending balance | $ (70.3) | (84.7) |
Accumulated Other Comprehensive Loss | Cumulative effect of adoption of ASU 2018-02 | ||
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Roll Forward] | ||
Beginning balance | $ (15.1) |
Stock-Based Compensation - Summ
Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Detail) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||
Stock-based compensation expense | $ 2 | $ 2.6 |
Stock-Based Compensation - Su_2
Stock-Based Compensation - Summary of Stock Option Activity (Detail) - Stock Options - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | 6 Months Ended | |
Mar. 31, 2020 | Jun. 30, 2019 | Dec. 31, 2019 | |
Stock Option Activity | |||
Shares, options outstanding, beginning balance | 409,296 | ||
Shares, forfeited/expired | (22,081) | ||
Shares, options outstanding, ending balance | 387,215 | ||
Weighted Average Exercise Price | |||
Weighted average exercise price, options outstanding (usd per share), beginning balance | $ 19.34 | ||
Weighted-average exercise price, forfeited/expired (usd per share) | 20.65 | ||
Weighted average exercise price, options outstanding (usd per share), ending balance | $ 19.27 | ||
Additional Disclosures | |||
Weighted average remaining contractual term options outstanding (years) | 2 years 1 month 6 days | 2 years 4 months 24 days | |
Aggregate intrinsic value, options outstanding | $ 0 | $ 0 |
Stock-Based Compensation - Su_3
Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Detail) - Restricted Stock Units (RSUs) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | 6 Months Ended | |
Mar. 31, 2020 | Jun. 30, 2019 | Dec. 31, 2019 | |
Equity Instruments Other than Options, Nonvested, Number of Shares | |||
Restricted stock units outstanding (shares), beginning balance | 2,731,758 | ||
Granted (shares) | 3,199,294 | ||
Vested and converted to shares (shares) | (997,868) | ||
Forfeited (shares) | (99,042) | ||
Restricted stock units outstanding (shares), ending balance | 4,834,142 | ||
Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | |||
Restricted stock units outstanding (usd per share), beginning balance | $ 5.02 | ||
Granted (usd per share) | 2.12 | ||
Vested and converted to shares (usd per share) | 6.90 | ||
Forfeited (usd per share) | 3.73 | ||
Restricted stock units outstanding (usd per share), ending balance | $ 2.74 | ||
Weighted average remaining contractual term options outstanding (years) | 1 year 7 months 6 days | 10 months 24 days | |
Restricted stock units outstanding, aggregate intrinsic value | $ 6.3 | $ 5.7 | |
Restricted stock units vested and outstanding (shares) | 54,472 | ||
Restricted stock units vested and outstanding (usd per share) | $ 8.26 | ||
Restricted stock units vested and outstanding, aggregate intrinsic value | $ 0.1 |
Stock-Based Compensation - Rest
Stock-Based Compensation - Restricted Stock and Restricted Stock Unit Compensation Information (Detail) - Restricted Stock Units (RSUs) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Weighted-average grant-date fair value of restricted stock units vested during the period | $ 6.9 | $ 8.9 |
Total intrinsic value of vested and converted shares | $ 2.5 | $ 2.5 |
Stock-Based Compensation - Addi
Stock-Based Compensation - Additional Information (Detail) - USD ($) | 3 Months Ended | |
Mar. 31, 2020 | Mar. 04, 2020 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Unrecognized stock option expense | $ 0 | |
Unrecognized restricted stock unit expense | $ 11,000,000 | |
Remaining weighted-average vesting period (years) | 2 years 4 months 24 days | |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost | $ 100,000 | |
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 1,919,406 | |
Common Stock, Capital Shares Reserved for Future Issuance | 1,279,888 | |
Potential increase to number of shares that may be issued under the plan | 8,900,000 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) - USD ($) $ in Millions | 3 Months Ended | |||
Mar. 31, 2020 | Mar. 31, 2019 | Dec. 31, 2019 | Jan. 15, 2019 | |
Income Tax Disclosure [Abstract] | ||||
Income tax expense | $ 9.7 | $ 6.6 | ||
(Loss) income before income taxes | (11.8) | $ (6.9) | ||
Deferred Tax Assets, Valuation Allowance | $ 10.1 | |||
Discrete tax expense related to Section 965 regulations | $ 0.7 | |||
Liability for unrecognized tax benefits | 18.2 | |||
Unrecognized tax benefits that if recognized could impact the effective tax rate | 18.2 | |||
Interest and penalties | 0.3 | |||
Income tax penalties and interest accrued | $ 8.6 | $ 8.3 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Millions | 1 Months Ended | 3 Months Ended | 6 Months Ended | 36 Months Ended | ||||
Nov. 30, 2018 | Mar. 31, 2020 | Sep. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2014 | Dec. 31, 2009 | Dec. 31, 2019 | Nov. 08, 2018 | |
Commitments and Contingencies [Line Items] | ||||||||
Loss contingency accrual | $ 57.5 | $ 57.5 | ||||||
Internal Revenue Service (IRS) [Member] | ||||||||
Commitments and Contingencies [Line Items] | ||||||||
Loss contingency accrual | 20.5 | |||||||
Deductions on securities losses | $ 900 | |||||||
Tax adjustments | $ 63.7 | $ 186.9 | ||||||
Cash payments for income taxes | $ 61 | |||||||
Deferred Prosecution Agreement [Member] | ||||||||
Commitments and Contingencies [Line Items] | ||||||||
Loss contingency accrual | $ 125 | |||||||
Payments for legal settlements | $ 70 | |||||||
Effect on future cash flows | $ 55 |
Earnings per Common Share - Wei
Earnings per Common Share - Weighted-Average Common Shares Basic and Diluted (Details) - shares shares in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Basic and diluted weighted-average outstanding common shares and equivalents used in computing loss per share | 77.4 | 64.8 |
Diluted | 76.4 | 64.5 |
Earnings per Common Share - Sch
Earnings per Common Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares shares in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Shares excluded from the computation | 9.2 | 3.8 |
Shares related to stock options | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Shares excluded from the computation | 0.4 | 1.3 |
Shares related to restricted stock units | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Shares excluded from the computation | 2.8 | 2.5 |
Shares related to warrants | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Shares excluded from the computation | 6 | 0 |
Segment Information - Additiona
Segment Information - Additional Information (Detail) | 3 Months Ended | |
Mar. 31, 2020segmentCustomer | Mar. 31, 2019Customer | |
Segment Reporting Information [Line Items] | ||
Number of reportable segments | segment | 2 | |
Percentage of total revenue | 14.00% | 16.00% |
Global Funds Transfer | ||
Segment Reporting Information [Line Items] | ||
Entity wide revenue major customer number | 1 | 1 |
Financial Paper Products | ||
Segment Reporting Information [Line Items] | ||
Entity wide revenue major customer number | 1 | 1 |
Segment Information - Revenue b
Segment Information - Revenue by Segment (Detail) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Segment Reporting Information [Line Items] | ||
Total revenue | $ 290.9 | $ 315.4 |
Global Funds Transfer | ||
Segment Reporting Information [Line Items] | ||
Total revenue | 269.3 | 289.2 |
Global Funds Transfer | Money transfer revenue | ||
Segment Reporting Information [Line Items] | ||
Total revenue | 255.9 | 273.3 |
Global Funds Transfer | Bill payment revenue | ||
Segment Reporting Information [Line Items] | ||
Total revenue | 13.4 | 15.9 |
Financial Paper Products | ||
Segment Reporting Information [Line Items] | ||
Total revenue | 21.6 | 26.2 |
Financial Paper Products | Money order revenue | ||
Segment Reporting Information [Line Items] | ||
Total revenue | 12.1 | 13.9 |
Financial Paper Products | Official check revenue | ||
Segment Reporting Information [Line Items] | ||
Total revenue | $ 9.5 | $ 12.3 |
Segment Information - Operating
Segment Information - Operating Income by Segment (Detail) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Segment Reporting Information [Line Items] | ||
Total operating income | $ 13.1 | $ 8.6 |
Interest expense | 23.8 | 13.9 |
Other non-operating expense | 1.1 | 1.6 |
Loss before income taxes | (11.8) | (6.9) |
Global Funds Transfer | ||
Segment Reporting Information [Line Items] | ||
Total operating income | 6.7 | 1.1 |
Financial Paper Products | ||
Segment Reporting Information [Line Items] | ||
Total operating income | 7 | 8.2 |
Total segment operating income | ||
Segment Reporting Information [Line Items] | ||
Total operating income | 13.7 | 9.3 |
Other | ||
Segment Reporting Information [Line Items] | ||
Total operating income | $ (0.6) | $ (0.7) |
Segment Information - Assets by
Segment Information - Assets by Segment (Detail) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Assets: | ||
Total assets | $ 3,895.7 | $ 4,185 |
Global Funds Transfer | ||
Assets: | ||
Total assets | 1,259.4 | 1,318.3 |
Financial Paper Products | ||
Assets: | ||
Total assets | 2,581.5 | 2,819.1 |
Other | ||
Assets: | ||
Total assets | $ 54.8 | $ 47.6 |
Revenue Recognition (Details)
Revenue Recognition (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Revenues | $ 290.9 | $ 315.4 |
Investment revenue | 10.1 | 14.4 |
Other revenue | ||
Revenues | 11.9 | 10.8 |
Total revenue from services and products | ||
Revenues | 268.9 | 290.2 |
Global Funds Transfer | ||
Revenues | 269.3 | 289.2 |
Global Funds Transfer | Money transfer fee revenue | ||
Revenues | 251.5 | 269.9 |
Global Funds Transfer | Bill payment services fee revenue | ||
Revenues | 13.4 | 15.9 |
Global Funds Transfer | Other revenue | ||
Revenues | 4.4 | 3.4 |
Global Funds Transfer | Total Global Funds Transfer fee and other revenue | ||
Revenues | 269.3 | 289.2 |
Financial Paper Products | ||
Revenues | 21.6 | 26.2 |
Financial Paper Products | Other revenue | ||
Revenues | 7.5 | 7.4 |
Financial Paper Products | Money order fee revenue | ||
Revenues | 2 | 2.3 |
Financial Paper Products | Official check outsourcing services fee revenue | ||
Revenues | 2 | 2.1 |
Financial Paper Products | Total Financial Paper Products fee and other revenue | ||
Revenues | 11.5 | 11.8 |
Services and products transferred at a point in time | ||
Revenues | 266.9 | 288.1 |
Products transferred over time | ||
Revenues | $ 2 | $ 2.1 |
Related Party Disclosures (Deta
Related Party Disclosures (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Dec. 31, 2019 | |
Related Party Transaction [Line Items] | ||
Common Stock, Shares, Issued | 64,434,490 | 65,061,090 |
Class of Warrant or Right, Outstanding | 5,957,600 | |
Business Development | $ 16.6 | |
Accounts Receivable, Related Parties | 0.9 | |
Other Indefinite-lived Intangible Assets | $ 3.1 | |
Securities Purchase Agreement (Ripple) [Member] | ||
Related Party Transaction [Line Items] | ||
Common Stock, Shares, Issued | 6,237,523 |